EverQuote (EVER) PT Lowered to $20 at Craig-Hallum Feb 24, 2026 09:30AM
EverQuote (EVER) PT Lowered to $25 at Needham Feb 24, 2026 07:07AM
EverQuote (EVER) PT Lowered to $28 at Canaccord Genuity Feb 24, 2026 06:54AM
After-hours movers: Hims & Hers Health, Keysight, Bed Bath & Beyond, Myriad Genetics, and more Feb 23, 2026 04:42PM
EverQuote (EVER) Tops Q4 EPS by $1.18, Offers Guidance Feb 23, 2026 04:22PM


Nov 3, 2025 04:27PM EverQuote (EVER) Tops Q3 EPS by 12c, provides guidance
Oct 6, 2025 02:56PM EverQuote (EVER) call put ratio 30 calls to 1 put with a focus on 5K contracts of December 25 calls
Sep 22, 2025 03:37AM Raymond James Downgrades EverQuote (EVER) to Outperform
Aug 11, 2025 08:31AM EverQuote repurchases $21 million in shares from chairman's entity
Aug 5, 2025 06:08AM EverQuote (EVER) PT Lowered to $29 at JPMorgan
Aug 5, 2025 02:53AM EverQuote (EVER) Tops Q2 EPS by 5c ; Offers Guidance
May 6, 2025 06:17AM Needham Reiterates Buy Rating on EverQuote (EVER)
May 5, 2025 04:25PM EverQuote (EVER) Misses Q1 EPS by 12c, provides guidance
Apr 1, 2025 05:32AM Goldmans Adjusted Monthly United States Director's Cut List
Feb 25, 2025 07:14AM EverQuote (EVER) PT Raised to $38 at Needham
Feb 24, 2025 04:50PM After-hours movers: Zoom, Hims & Hers Health, Tempus AI, and more
Feb 24, 2025 04:42PM EverQuote (EVER) Tops Q4 EPS by 14c
Dec 27, 2024 03:00PM Raymond James' top picks under Insurance categories
Dec 26, 2024 05:34AM Raymond James Upgrades EverQuote (EVER) to Strong Buy
Nov 5, 2024 07:12AM EverQuote (EVER) PT Lowered to $30 at Needham
Nov 5, 2024 06:16AM Canaccord Genuity Reiterates Buy Rating on EverQuote (EVER)
Nov 4, 2024 04:58PM EverQuote (EVER) Tops Q3 EPS by 10c, provides guidance
Aug 6, 2024 08:43AM EverQuote (EVER) PT Raised to $33 at Craig-Hallum
Aug 6, 2024 07:43AM EverQuote (EVER) PT Raised to $36.50 at B.Riley
Aug 6, 2024 07:18AM EverQuote (EVER) PT Raised to $38 at Needham
Aug 5, 2024 04:55PM EverQuote (EVER) Tops Q2 EPS by 14c, provides guidance